TSXV - Delayed Quote • CAD Aurora Spine Corporation (ASG.V) Follow Compare 0.4800 +0.0300 +(6.67%) At close: 1:45:06 PM EST All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Cannabix Technologies And 2 Other TSX Penny Stocks To Watch As we move into 2025, the Canadian market continues to navigate a landscape of both opportunities and challenges, buoyed by the strong performance seen in 2024. For investors looking beyond established giants, penny stocks offer intriguing possibilities; these smaller or newer companies can surprise with their potential for growth and value. Despite their vintage name, penny stocks remain relevant today, especially when backed by solid financials that suggest resilience and potential... 3 Promising TSX Penny Stocks Over CA$9M Market Cap The Canadian market has shown resilience, supported by robust consumer spending and positive real wage growth, even amidst challenges like elevated inflation and higher interest rates. In this context, penny stocks—often smaller or newer companies—can present intriguing opportunities when underpinned by strong financials. We'll explore three such Canadian penny stocks that exemplify financial strength and potential for growth in today's economic landscape. Aurora Spine Corp (ASAPF) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... Aurora Spine Corp (ASAPF) reports a 21% revenue increase and a return to profitability in Q3 2024, driven by robust sales and improved margins. TSX Penny Stocks To Watch In October 2024 Over the last 7 days, the Canadian market has remained flat, but it is up 27% over the past year with earnings expected to grow by 16% annually in the coming years. For those interested in smaller or newer companies, penny stocks—despite their somewhat outdated name—can still offer surprising value when backed by strong financials. In this article, we explore three penny stocks that demonstrate financial strength and potential for long-term growth. Aurora Spine Reports Third Quarter 2024 Earnings Aurora Spine ( CVE:ASG ) Third Quarter 2024 Results Key Financial Results Revenue: US$4.77m (up 21% from 3Q 2023). Net... Aurora Spine Corporation Schedules Conference Call to Update Investors and Discuss Third Quarter Fiscal Year 2024 Financial Results CARLSBAD, Calif., Oct. 25, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it has scheduled a conference call to update investors and discuss its third quarter fiscal 2024 financial results that ended September 30, 2024. Management will host the conference call on Monday October 28, 2024 at 11:00 a.m. Eastern Time. Third Q Aurora Spine Corporation Announces Third Quarter 2024 Financial Results - Company reports record revenue and net income - - Company to host conference call on Monday, October 28th at 11am ET/8am PT - NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in spine and interventional spine technology that improves spinal surgery outcomes, today announced its financial results for third quarter ended Aurora Spine Corporation Announces Release of its Hydra Osteo Onyx Lumbar System CARLSBAD, Calif., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it has launched its new OSTEO ONYX™ lumbar fusion system, promoting Rough Surface Technology (RST). “We are excited to introduce another procedural solution that accommodates not only standard spine patients but the most challenging patients who are Aurora Spine Corporation Announces Participation at the North American Spine Society Annual Meeting Company to Showcase Cutting-Edge Innovations at Booth #4510CARLSBAD, Calif., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a leader in the development of groundbreaking medical devices for spinal surgery, today announced its participation at the 2024 North American Spine Society ("NASS") Annual Meeting. The event will take place from September 25-28, 2024, at McCormick Place, West Building, in Chicago, Illinois. Aurora S Aurora Spine to Host ZOOM Call with Alpha Wolf Trading CEO Tim Weintraut CARLSBAD, CA, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, is excited to announce a recorded ZOOM call on September 13, 2024 with Trent Northcutt, CEO of Aurora Spine, and Tim Weintraut, CEO of Alpha Wolf Trading/Blog. The conversation will focus on Aurora's latest innovations, exciting clinical results, and the company's con Aurora Spine Corporation to Attend Latin America Pain Society (LAPS) Conference, Showcasing Innovations in Pain Management and Spine Care for Emerging Markets CARLSBAD, Calif., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced its participation in the upcoming Latin America Pain Society (LAPS) Annual Congress September 5-7, 2024, in Mexico City. The event will provide Aurora Spine with a platform to present its latest advancements in minimally invasive spinal devices and Aurora Spine Second Quarter 2024 Earnings: US$0.023 loss per share (vs US$0.007 loss in 2Q 2023) Aurora Spine ( CVE:ASG ) Second Quarter 2024 Results Key Financial Results Revenue: US$4.08m (up 14% from 2Q 2023). Net... Aurora Spine Corporation Announces Second Quarter 2024 Financial Results NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in spine and interventional spine technology that improves spinal surgery outcomes, today announced its financial results for second quarter ended June 30, 2024. All figures are in U.S. dollars. Financial and Business Highlights Continued Positive EBITDAC – Q2 2024 EBITDAC Aurora Spine Corporation to Attend Sixth Annual American Society of Pain & Neuroscience Conference CARLSBAD, Calif., July 10, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it will be participating in the Sixth Annual ASPN Conference sponsored by The American Society of Pain Neuroscience (ASPN) to be held July 11-14, 2024 at the Fontainebleau in Miami Beach, Florida. Aurora will be located at Booth 121. On July 12th, a We Think Shareholders May Want To Consider A Review Of Aurora Spine Corporation's (CVE:ASG) CEO Compensation Package Key Insights Aurora Spine to hold its Annual General Meeting on 26th of June Total pay for CEO Trent Northcutt includes... Aurora Spine Corporation Announces First Quarter 2024 Financial Results NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in spine and interventional spine technology that improves spinal surgery outcomes, today announced its financial results for first quarter ended March 31, 2024. All figures are in U.S. dollars. Financial and Business Highlights Positive EBITDAC – Q1 2024 EBITDAC was $117,17 Aurora Spine Corporation Schedules Conference Call to Update Investors and Discuss First Quarter Fiscal Year 2024 Financial Results CARLSBAD, Calif. , May 13, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it has scheduled a conference call to update investors and discuss its first quarter fiscal 2024 financial results that ended March 31, 2024. Management will host the conference call on Tuesday May 14, 2024 at 11:00 a.m. Eastern Time. First Quarter Aurora Spine Full Year 2023 Earnings: US$0.02 loss per share (vs US$0.022 loss in FY 2022) Aurora Spine ( CVE:ASG ) Full Year 2023 Results Key Financial Results Revenue: US$14.5m (down 2.4% from FY 2022). Net... Aurora Spine Corporation Announces Fourth Quarter and Fiscal 2023 Financial Results NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in spine and interventional spine technology that improves spinal surgery outcomes, today announced its financial results for fiscal 2023 ended December 31, 2023. The company experienced strong, successive, quarter over quarter revenue growth, while overcoming early year o Aurora Spine Corporation Celebrates Second Anniversary of Initial Implantation of the World’s First Bone Density Matched DEXA-C Cervical Interbody Fusion Device CARLSBAD, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a manufacturer of innovative spinal implants announced today that it has completed the second full year of implantation of the world’s first patient-bone-density matched interbody device, the cervical interbody DEXA-C. Trent Northcutt, CEO and President at Aurora Spine said, "It's a significant milestone for Aurora to celebrate the second anniversary of the Performance Overview Trailing total returns as of 1/16/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index Return ASG.V S&P/TSX Composite index YTD +20.00% +0.92% 1-Year +23.08% +17.97% 3-Year +54.84% +16.33%